Browsing Tag
respiratory care
5 posts
Lupin (NSE: LUPIN) goes big in the U.S.—$250m Coral Springs facility sparks investor buzz
Find out how Lupin’s $250 million Coral Springs manufacturing facility could redefine America’s respiratory drug security and boost U.S. pharma resilience.
Lupin signs China licensing deal for COPD drug Tiotropium DPI with Sino Universal Pharmaceuticals
Lupin enters China’s COPD market with a Tiotropium DPI licensing deal. Learn how this move shapes its global respiratory growth strategy.
Yuwell Medical partners with Inogen to revolutionize global respiratory care
Yuwell Medical, a leader in home medical devices, has unveiled a groundbreaking partnership with U.S.-based Inogen, a renowned…
Lupin Limited expands global specialty portfolio with strategic acquisitions
Global pharmaceutical leader Lupin Limited (Lupin) has announced the completion of a strategic acquisition through its European hub,…
Is this Lupin’s next U.S. respiratory blockbuster? Generic Perforomist hits the shelves
Lupin launches generic Perforomist in the U.S. for asthma and COPD, eyeing a $268M market. Find out how this move boosts its global respiratory portfolio.